nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.641	1	CbGbCtD
Tranylcypromine—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0456	0.148	CcSEcCtD
Tranylcypromine—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0262	0.0849	CcSEcCtD
Tranylcypromine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0537	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0111	0.036	CcSEcCtD
Tranylcypromine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00961	0.0312	CcSEcCtD
Tranylcypromine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00769	0.0249	CcSEcCtD
Tranylcypromine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00687	0.0223	CcSEcCtD
Tranylcypromine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00679	0.022	CcSEcCtD
Tranylcypromine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00577	0.0187	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00575	0.0187	CcSEcCtD
Tranylcypromine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00534	0.0173	CcSEcCtD
Tranylcypromine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00519	0.0169	CcSEcCtD
Tranylcypromine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00509	0.0165	CcSEcCtD
Tranylcypromine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00502	0.0163	CcSEcCtD
Tranylcypromine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.005	0.0162	CcSEcCtD
Tranylcypromine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.005	0.0162	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00497	0.0161	CcSEcCtD
Tranylcypromine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0145	CcSEcCtD
Tranylcypromine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00442	0.0143	CcSEcCtD
Tranylcypromine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0136	CcSEcCtD
Tranylcypromine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0132	CcSEcCtD
Tranylcypromine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00402	0.013	CcSEcCtD
Tranylcypromine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.004	0.013	CcSEcCtD
Tranylcypromine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0127	CcSEcCtD
Tranylcypromine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0126	CcSEcCtD
Tranylcypromine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00384	0.0125	CcSEcCtD
Tranylcypromine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0124	CcSEcCtD
Tranylcypromine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0122	CcSEcCtD
Tranylcypromine—MAOB—nerve—amyotrophic lateral sclerosis	0.00372	0.0987	CbGeAlD
Tranylcypromine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00369	0.012	CcSEcCtD
Tranylcypromine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0118	CcSEcCtD
Tranylcypromine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0116	CcSEcCtD
Tranylcypromine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0115	CcSEcCtD
Tranylcypromine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00349	0.0113	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0113	CcSEcCtD
Tranylcypromine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0112	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00343	0.0111	CcSEcCtD
Tranylcypromine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00338	0.011	CcSEcCtD
Tranylcypromine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0108	CcSEcCtD
Tranylcypromine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0104	CcSEcCtD
Tranylcypromine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0103	CcSEcCtD
Tranylcypromine—MAOA—nerve—amyotrophic lateral sclerosis	0.00317	0.0842	CbGeAlD
Tranylcypromine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0102	CcSEcCtD
Tranylcypromine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00309	0.01	CcSEcCtD
Tranylcypromine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00985	CcSEcCtD
Tranylcypromine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00985	CcSEcCtD
Tranylcypromine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00949	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00942	CcSEcCtD
Tranylcypromine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00915	CcSEcCtD
Tranylcypromine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00911	CcSEcCtD
Tranylcypromine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00911	CcSEcCtD
Tranylcypromine—MAOB—hindbrain—amyotrophic lateral sclerosis	0.00279	0.0739	CbGeAlD
Tranylcypromine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00826	CcSEcCtD
Tranylcypromine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00788	CcSEcCtD
Tranylcypromine—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00238	0.063	CbGeAlD
Tranylcypromine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00762	CcSEcCtD
Tranylcypromine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00732	CcSEcCtD
Tranylcypromine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00726	CcSEcCtD
Tranylcypromine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00726	CcSEcCtD
Tranylcypromine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00722	CcSEcCtD
Tranylcypromine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00684	CcSEcCtD
Tranylcypromine—MAOB—embryo—amyotrophic lateral sclerosis	0.00174	0.0462	CbGeAlD
Tranylcypromine—MAOB—brainstem—amyotrophic lateral sclerosis	0.0016	0.0424	CbGeAlD
Tranylcypromine—MAOA—embryo—amyotrophic lateral sclerosis	0.00149	0.0394	CbGeAlD
Tranylcypromine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00141	0.0375	CbGeAlD
Tranylcypromine—MAOA—brainstem—amyotrophic lateral sclerosis	0.00136	0.0361	CbGeAlD
Tranylcypromine—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.00111	0.0295	CbGeAlD
Tranylcypromine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.00107	0.0283	CbGeAlD
Tranylcypromine—MAOB—spinal cord—amyotrophic lateral sclerosis	0.000993	0.0263	CbGeAlD
Tranylcypromine—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.00095	0.0252	CbGeAlD
Tranylcypromine—CYP2A6—brain—amyotrophic lateral sclerosis	0.000867	0.023	CbGeAlD
Tranylcypromine—MAOA—spinal cord—amyotrophic lateral sclerosis	0.000847	0.0225	CbGeAlD
Tranylcypromine—MAOB—nervous system—amyotrophic lateral sclerosis	0.000837	0.0222	CbGeAlD
Tranylcypromine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00081	0.0215	CbGeAlD
Tranylcypromine—MAOB—central nervous system—amyotrophic lateral sclerosis	0.000806	0.0214	CbGeAlD
Tranylcypromine—MAOB—cerebellum—amyotrophic lateral sclerosis	0.000787	0.0209	CbGeAlD
Tranylcypromine—MAOA—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.000741	0.0574	CbGpPWpGaD
Tranylcypromine—MAOB—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.000729	0.0565	CbGpPWpGaD
Tranylcypromine—MAOA—nervous system—amyotrophic lateral sclerosis	0.000714	0.0189	CbGeAlD
Tranylcypromine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000713	0.0189	CbGeAlD
Tranylcypromine—MAOA—central nervous system—amyotrophic lateral sclerosis	0.000687	0.0182	CbGeAlD
Tranylcypromine—MAOA—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000679	0.0526	CbGpPWpGaD
Tranylcypromine—MAOA—cerebellum—amyotrophic lateral sclerosis	0.000672	0.0178	CbGeAlD
Tranylcypromine—MAOB—brain—amyotrophic lateral sclerosis	0.00064	0.017	CbGeAlD
Tranylcypromine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000636	0.0169	CbGeAlD
Tranylcypromine—MAOA—brain—amyotrophic lateral sclerosis	0.000546	0.0145	CbGeAlD
Tranylcypromine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000536	0.0142	CbGeAlD
Tranylcypromine—MAOA—Oxidative Stress—GSR—amyotrophic lateral sclerosis	0.000518	0.0401	CbGpPWpGaD
Tranylcypromine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000516	0.0137	CbGeAlD
Tranylcypromine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000504	0.0134	CbGeAlD
Tranylcypromine—MAOA—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.000458	0.0354	CbGpPWpGaD
Tranylcypromine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000431	0.0114	CbGeAlD
Tranylcypromine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000424	0.0113	CbGeAlD
Tranylcypromine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000415	0.011	CbGeAlD
Tranylcypromine—CYP2E1—brain—amyotrophic lateral sclerosis	0.00041	0.0109	CbGeAlD
Tranylcypromine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000408	0.0108	CbGeAlD
Tranylcypromine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000399	0.0106	CbGeAlD
Tranylcypromine—MAOA—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.000325	0.0252	CbGpPWpGaD
Tranylcypromine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000324	0.0086	CbGeAlD
Tranylcypromine—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000321	0.0249	CbGpPWpGaD
Tranylcypromine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000316	0.0245	CbGpPWpGaD
Tranylcypromine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000299	0.0232	CbGpPWpGaD
Tranylcypromine—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000295	0.0229	CbGpPWpGaD
Tranylcypromine—MAOA—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00029	0.0225	CbGpPWpGaD
Tranylcypromine—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00025	0.0194	CbGpPWpGaD
Tranylcypromine—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000248	0.0192	CbGpPWpGaD
Tranylcypromine—MAOA—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	0.000234	0.0182	CbGpPWpGaD
Tranylcypromine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00021	0.0163	CbGpPWpGaD
Tranylcypromine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00018	0.0139	CbGpPWpGaD
Tranylcypromine—MAOA—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000178	0.0138	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000177	0.0137	CbGpPWpGaD
Tranylcypromine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—amyotrophic lateral sclerosis	0.000152	0.0118	CbGpPWpGaD
Tranylcypromine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000139	0.0107	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000123	0.00954	CbGpPWpGaD
Tranylcypromine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.00012	0.00928	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000114	0.00882	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000114	0.00882	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000114	0.00882	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000114	0.0088	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000113	0.00879	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00011	0.0085	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0001	0.00777	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	9.43e-05	0.00731	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	9.33e-05	0.00723	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	9.33e-05	0.00723	CbGpPWpGaD
Tranylcypromine—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.02e-05	0.00698	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—GRIA2—amyotrophic lateral sclerosis	8.7e-05	0.00674	CbGpPWpGaD
Tranylcypromine—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	8.41e-05	0.00652	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	8.41e-05	0.00651	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	8.32e-05	0.00644	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	8.3e-05	0.00643	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.76e-05	0.00601	CbGpPWpGaD
Tranylcypromine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.74e-05	0.00599	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	7.69e-05	0.00596	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	7.15e-05	0.00554	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	7.15e-05	0.00554	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	6.91e-05	0.00535	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	6.91e-05	0.00535	CbGpPWpGaD
Tranylcypromine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.61e-05	0.00512	CbGpPWpGaD
Tranylcypromine—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	6.55e-05	0.00508	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	6.4e-05	0.00496	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	6.37e-05	0.00494	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	6.32e-05	0.00489	CbGpPWpGaD
Tranylcypromine—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.03e-05	0.00467	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.98e-05	0.00464	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	5.89e-05	0.00456	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.87e-05	0.00455	CbGpPWpGaD
Tranylcypromine—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.66e-05	0.00438	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	5.52e-05	0.00428	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.5e-05	0.00426	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.46e-05	0.00423	CbGpPWpGaD
Tranylcypromine—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.15e-05	0.00399	CbGpPWpGaD
Tranylcypromine—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	5.07e-05	0.00393	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	5.01e-05	0.00388	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	4.99e-05	0.00387	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.66e-05	0.00361	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.61e-05	0.00357	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.39e-05	0.0034	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	4.34e-05	0.00336	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	4.34e-05	0.00336	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.21e-05	0.00326	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.2e-05	0.00325	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	3.96e-05	0.00307	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.92e-05	0.00303	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.84e-05	0.00298	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	3.79e-05	0.00293	CbGpPWpGaD
Tranylcypromine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.73e-05	0.00289	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.69e-05	0.00286	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.68e-05	0.00285	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.6e-05	0.00279	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.59e-05	0.00278	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.57e-05	0.00277	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	3.57e-05	0.00276	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	3.49e-05	0.00271	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.47e-05	0.00269	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	3.47e-05	0.00268	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.42e-05	0.00265	CbGpPWpGaD
Tranylcypromine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.4e-05	0.00263	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.37e-05	0.00261	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.37e-05	0.00261	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.36e-05	0.0026	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.28e-05	0.00254	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	3.13e-05	0.00243	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.1e-05	0.00241	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.08e-05	0.00238	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.05e-05	0.00236	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	2.94e-05	0.00228	CbGpPWpGaD
Tranylcypromine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.9e-05	0.00225	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.87e-05	0.00222	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.87e-05	0.00222	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.86e-05	0.00222	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.69e-05	0.00208	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.68e-05	0.00207	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.66e-05	0.00206	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.66e-05	0.00206	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.64e-05	0.00205	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.52e-05	0.00196	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.5e-05	0.00193	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.46e-05	0.00191	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.45e-05	0.00189	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.44e-05	0.00189	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	2.43e-05	0.00188	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.43e-05	0.00188	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.43e-05	0.00188	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.41e-05	0.00187	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	2.38e-05	0.00184	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.3e-05	0.00178	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.26e-05	0.00175	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	2.19e-05	0.0017	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.13e-05	0.00165	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.09e-05	0.00162	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.06e-05	0.00159	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.05e-05	0.00159	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.05e-05	0.00159	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.97e-05	0.00152	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.92e-05	0.00149	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.91e-05	0.00148	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.89e-05	0.00146	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.89e-05	0.00146	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.88e-05	0.00145	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.87e-05	0.00145	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.87e-05	0.00145	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.84e-05	0.00143	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	1.8e-05	0.00139	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.74e-05	0.00135	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.74e-05	0.00135	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.73e-05	0.00134	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.71e-05	0.00133	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.7e-05	0.00132	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.64e-05	0.00127	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.61e-05	0.00125	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.6e-05	0.00124	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.6e-05	0.00124	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.6e-05	0.00124	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.59e-05	0.00123	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.59e-05	0.00123	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.54e-05	0.00119	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.51e-05	0.00117	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.5e-05	0.00116	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.49e-05	0.00115	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.48e-05	0.00115	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.46e-05	0.00113	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.46e-05	0.00113	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.42e-05	0.0011	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.4e-05	0.00108	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.36e-05	0.00106	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.36e-05	0.00105	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.35e-05	0.00105	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.34e-05	0.00104	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.28e-05	0.00099	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.23e-05	0.000956	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.23e-05	0.000956	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	1.17e-05	0.000903	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.16e-05	0.000895	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.13e-05	0.000874	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.12e-05	0.000871	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.1e-05	0.000856	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.05e-05	0.000813	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.04e-05	0.000804	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.03e-05	0.000801	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.03e-05	0.000794	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	9.86e-06	0.000764	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.67e-06	0.000749	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	9.54e-06	0.000739	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	9.46e-06	0.000733	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.45e-06	0.000732	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	8.92e-06	0.000691	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.89e-06	0.000689	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.76e-06	0.000679	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.62e-06	0.000667	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	8.52e-06	0.00066	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	8.08e-06	0.000626	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.99e-06	0.000619	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.84e-06	0.000607	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.77e-06	0.000602	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	7.77e-06	0.000602	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.51e-06	0.000582	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.36e-06	0.00057	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	7.32e-06	0.000567	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.09e-06	0.000549	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.9e-06	0.000535	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.76e-06	0.000524	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.64e-06	0.000514	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.24e-06	0.000483	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.06e-06	0.000469	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.94e-06	0.00046	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	5.68e-06	0.00044	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.45e-06	0.000423	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.33e-06	0.000413	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.12e-06	0.000397	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.01e-06	0.000388	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.86e-06	0.000376	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.58e-06	0.000355	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	4.49e-06	0.000348	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.21e-06	0.000326	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.21e-06	0.000326	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.18e-06	0.000323	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.15e-06	0.000322	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.89e-06	0.000301	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.87e-06	0.0003	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.84e-06	0.000297	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.57e-06	0.000276	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.46e-06	0.000268	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.28e-06	0.000254	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.18e-06	0.000247	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.16e-06	0.000245	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.08e-06	0.000238	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.75e-06	0.000213	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.7e-06	0.000209	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.53e-06	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.37e-06	0.000184	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.18e-06	0.000169	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.16e-06	0.000168	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.08e-06	0.000161	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.85e-06	0.000143	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.43e-06	0.000111	CbGpPWpGaD
